# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k170049   
B. Purpose for Submission: Addition of oxazepam, methylenedioxymethamphetamine, and morphine ( $3 0 0 ~ \mathrm { { n g / m L } }$ cutoff) to a previously cleared device   
C. Measurand: Amphetamine, Marijuana, Cocaine, Methamphetamine, Morphine, Oxazepam, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxymethamphetamine, Phencyclidine, Methadone   
D. Type of Test: Qualitative immunochromatographic assay   
E. Applicant: Assure Tech. Co, Ltd.   
F. Proprietary and Established Names: AssureTech Panel Dip Tests AssureTech Quick Cup Tests   
G. Regulatory Information:

<table><tr><td colspan="1" rowspan="1">Product Code</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">Regulation Section</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">NFT</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3100, Amphetamine Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NFW</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3870, Cannabinoids Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NFY</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR 862.3250, Cocaine and CocaineMetabolites Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NGG</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3610,Methamphetamine Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NFV</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3170,Benzodiazepine Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">PTH</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3150, Barbiturate Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NGL</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3650,Opiate Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">NGM</td><td colspan="1" rowspan="1">unclassified</td><td colspan="1" rowspan="1">Enzyme Immunoassay Phencyclidine</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr><tr><td colspan="1" rowspan="1">PTG</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR 862.3620, Methadone Test System</td><td colspan="1" rowspan="1">Toxicology(91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See Indications for Use below.

2. Indication(s) for use:

AssureTech Panel Dip Tests and AssureTech Quick Cup Tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine and Methadone in human urine at the cutoff concentrations of:

Drug(Identifier)   
Amphetamine   
Oxazepam   
Cocaine   
Marijuana   
Methamphetamine   
Morphine   
Oxycodone   
Secobarbital   
Buprenorphine   
Methylenedioxy-methamphetamine   
Phencyclidine   
Methadone

Cut-off level   
1000 ng/mL   
300 ng/mL   
300 ng/mL   
50 ng/mL   
1000 ng/mL   
$3 0 0 ~ \mathrm { { n g / m L } }$ or 2000 ng/mL   
100 ng/mL   
300 ng/mL   
10 ng/mL   
500 ng/mL   
25 ng/mL   
300 ng/mL

Configuration of the AssureTech Panel Dip Tests and the AssureTech Quick Cup Tests can consist of any combination of the above listed drug analytes.

The test may yield positive results for the prescription drugs Buprenorphine, Oxazepam, Secobarbital and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method.

These tests are intended for over-the counter and for prescription use.

3. Special conditions for use statement(s): For prescription or over-the-counter use.

4. Special instrument requirements: Not applicable; this is a visually read single use device.

# I. Device Description:

The AssureTech Panel Dip Tests and AssureTech Quick Cup Tests are immunochromatographic assays that use a lateral flow system for the qualitative detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxymethamphetamine, Phencyclidine and Methadone (target analytes) in human urine. The tests are the first step in a two-step process.

The AssureTech Panel Dip Tests comprise two items, a urine collection cup and the dip card with a plastic casing as the lateral flow device. The AssureTech Quick Cup Tests comprise a urine collection cup and a quick cup test with a lateral flow device that will start when the cap is screwed onto cup.

# J. Substantial Equivalence Information:

1. Predicate device name(s): The Chemtrue $^ \mathrm { \textregistered }$ Multi-Panel Drug Screen Dip Card Tests

2. Predicate 510(k) number(s): k142396

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Candidate Devices:AssureTech Panel Dip Tests and AssureTech Quick Cup Tests</td><td rowspan=1 colspan=1>Chemtru Multi-PanelDrug Screen Dip Cardk142396</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination of drugs ofabuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyte and Cut-Off Values</td><td rowspan=1 colspan=1>Amphetamine (AMP): 1,000 ng/mlOxazepam (BZO): 300 ng/mlCocaine (COC): 300 ng/mlMarijuana (THC): 50 ng/mlMethamphetamine (MET): 1,000 ng/mlMorphine (MOR): 300ng/mL or 2000 ng/mlOxycodone (OXY): 100 ng/mlSecobarbital (BAR): 300 ng/mlBuprenorphine (BUP): 10 ng/mlMethylenedioxymethamphetamine(MDMA):500 ng/mlPhencyclidine (PCP): 25 ng/mlMethadone (MTD): 300 ng/ml</td><td rowspan=1 colspan=1>Same; but also Nortriptyline(1000 ng/mL cutoff)</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays based on theprinciple of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For over-the-counter and prescription uses.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Dip Card, Cup</td><td rowspan=1 colspan=1>Dip Card</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Not applicable.

# L. Test Principle:

The AssureTech Panel Dip Tests, and AssureTech Quick Cup Tests are rapid tests for the qualitative detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxymethamphetamine, Phencyclidine and Methadone in urine samples. The tests are lateral flow chromatographic immunoassays. During testing, a urine specimen migrates upward by capillary action. If a target drug present in the urine specimen is below the cut-off concentration, it will not saturate the binding sites of its specific monoclonal mouse antibody coated on gold particles. The antibody-coated particles will then be captured by immobilized drug-conjugate in the test line region and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the target drug level exceeds its cutoff-concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices (coated with anti-mouse antibodies) regardless of the presence of drug or metabolite in the sample to indicate that the tests have been performed properly.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

Precision studies were carried out for samples with concentrations of - $. 1 0 0 \%$ cut-off, - $7 5 \%$ cut-off, $- 5 0 \%$ cut-off, $- 2 5 \%$ cut-off, cut-off, $+ 2 5 \%$ cut-off, $+ 5 0 \%$ cut-off, $+ 7 5 \%$ cutoff and $+ 1 0 0 \%$ cut-off. The samples used in the precision studies were prepared by spiking drug into negative urine samples. Each drug concentration was confirmed by LC/MS. All sample aliquots were blindly labeled by the person who prepared the samples and who did not take part in the sample testing. For each concentration, tests were performed two runs per day for 25 days per device in a randomized order. The results obtained are summarized in the following tables for Oxazepam,

Methylenedioxymethamphetamine and Morphine. The precision data for the remaining drugs of abuse devices were reported in k153465, k151211, k152025, and k161044.

# Oxazepam

Panel Dip

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut-off</td><td rowspan=1 colspan=1>-75%cut-off</td><td rowspan=1 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%cut-off</td><td rowspan=1 colspan=1>cut-off</td><td rowspan=1 colspan=1>+25%cut-off</td><td rowspan=1 colspan=1>+50%cut-off</td><td rowspan=1 colspan=1>+75%cut-off</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>9-/41+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>10-/40+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>10-/40+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Quick Cup

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut-off</td><td rowspan=1 colspan=1>-75%cut-off</td><td rowspan=1 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%cut-off</td><td rowspan=1 colspan=1>cut-off</td><td rowspan=1 colspan=1>+25%cut-off</td><td rowspan=1 colspan=1>+50%cut-off</td><td rowspan=1 colspan=1>+75%cut-off</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>8-/42+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>9-/41+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# Methylenedioxymethamphetamine

Panel Dip

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut-off</td><td rowspan=1 colspan=1>-75%cut-off</td><td rowspan=1 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%cut-off</td><td rowspan=1 colspan=1>cut-off</td><td rowspan=1 colspan=1>+25%cut-off</td><td rowspan=1 colspan=1>+50%cut-off</td><td rowspan=1 colspan=1>+75%cut-off</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>13-/37+</td><td rowspan=1 colspan=1>50+0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Quick Cup

<table><tr><td rowspan=2 colspan=1>LotNumber</td><td rowspan=2 colspan=1>-100%cut-off</td><td rowspan=2 colspan=1>-75%cut-off</td><td rowspan=2 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%</td><td rowspan=2 colspan=1>cut-off</td><td rowspan=2 colspan=1>+25%cut-off</td><td rowspan=2 colspan=1>+50%cut-off</td><td rowspan=2 colspan=1>+75%cut-off</td><td rowspan=2 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>9-/41+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>12-/38+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# Morphine (300 ng/mL Cut-off)

Panel Dip

<table><tr><td rowspan=2 colspan=1>LotNumber</td><td rowspan=2 colspan=1>-100%cut-off</td><td rowspan=2 colspan=1>-75%cut-off</td><td rowspan=2 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%</td><td rowspan=2 colspan=1>cut-off</td><td rowspan=2 colspan=1>+25%cut-off</td><td rowspan=2 colspan=1>+50%cut-off</td><td rowspan=2 colspan=1>+75%cut-off</td><td rowspan=2 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>11-/39+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Quick Cup

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut-off</td><td rowspan=1 colspan=1>-75%cut-off</td><td rowspan=1 colspan=1>-50%cut-off</td><td rowspan=1 colspan=1>-25%cut-off</td><td rowspan=1 colspan=1>cut-off</td><td rowspan=1 colspan=1>+25%cut-off</td><td rowspan=1 colspan=1>+50%cut-off</td><td rowspan=1 colspan=1>+75%cut-off</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>8-/42+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>9-/41+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>9-/41+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# $b$ . Linearity/assay reportable range:

Not applicable, these devices are intended for qualitative use only.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

External control materials are not supplied with the devices.

The devices are stable at $4 - 3 0 ^ { \circ } \mathrm { C }$ for 24 months based on accelerated and real-time stability studies. Real time stability studies are ongoing.

d. Detection limit: Not applicable.

e. Analytical specificity:

Specificity:

To test specificity, drug metabolites and other components that are likely to interfere in urine samples were tested using three batches of each device. The lowest concentration that caused a positive result for each compound is listed below for Oxazepam,

Methylenedioxymethamphetamine and Morphine. The data for the remaining drugs of abuse devices were reported in k153465, k151211, k152025, and k161044. There were no differences observed for different devices.

<table><tr><td colspan="1" rowspan="1">Oxazepam(Cut-off = 300 ng/mL)</td><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">a-Hydroxyalprazolam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Chiordiazepoxide</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">476.2%</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">12%</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Clorazepate dipotassium</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300%</td></tr><tr><td colspan="1" rowspan="1">Desalkylflurazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">&lt;0.6%</td></tr><tr><td colspan="1" rowspan="1">D,L-Lorazepam</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">3%</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">3%</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Norchiordiazepoxide</td><td colspan="1" rowspan="1">62.5</td><td colspan="1" rowspan="1">480%</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">125</td><td colspan="1" rowspan="1">240%</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Trazolam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxymethamphetamine(Cut-off = 500 ng/mL)</td><td colspan="1" rowspan="1">ResultPositive at(ng/ml)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">166.7%</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">1-amphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">1-methamphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">&lt;1%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Morphine(Cut-off = 300ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at (ng/ml)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>310</td><td rowspan=1 colspan=1>96.8%</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>25000</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphine</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>0.3%</td></tr><tr><td rowspan=1 colspan=1>6-Acetylmorphine</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>120%</td></tr><tr><td rowspan=1 colspan=1>Morphine 3-β-D-glucuronide</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Normorphine</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>0.3%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Heroine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>60%</td></tr></table>

Interference:

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and urine with target drug concentrations at $2 5 \%$ below and $2 5 \%$ above cut-off levels. These urine samples were tested using three lots of each device. The compounds in the following table were tested at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ , and did not show positive or negative interference. Albumin at a concentration of $1 0 0 \mathrm { m g / d L }$ did not cause positive or negative interference. There were no differences observed for different devices.

<table><tr><td rowspan=1 colspan=1>Acetominophen</td><td rowspan=1 colspan=1>EMDP</td><td rowspan=1 colspan=1>Oxalic acid</td></tr><tr><td rowspan=1 colspan=1>Acetophenetidin</td><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>Oxolinic acid</td></tr><tr><td rowspan=1 colspan=1>N-Acetylprocainamide</td><td rowspan=1 colspan=1>β-Estradiol</td><td rowspan=1 colspan=1>Oxymetazoline</td></tr><tr><td rowspan=1 colspan=1>Albumin (100 mg/dL)</td><td rowspan=1 colspan=1>Fenoprofen</td><td rowspan=1 colspan=1>Papaverine</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic acid</td><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>Penicillin-G</td></tr><tr><td rowspan=1 colspan=1>Aminopyrine</td><td rowspan=1 colspan=1>Gentisic acid</td><td rowspan=1 colspan=1>Perphenazine</td></tr><tr><td rowspan=1 colspan=1>Amoxicillin</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Phenelzine</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>Hydralazine</td><td rowspan=1 colspan=1>Prednisone</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>Hydrochlorothiazide</td><td rowspan=1 colspan=1>DL-Propranolol</td></tr><tr><td rowspan=1 colspan=1>Apomorphine</td><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>D-Pseudoephedrine</td></tr><tr><td rowspan=1 colspan=1>Aspartame</td><td rowspan=1 colspan=1>O-Hydroxyhippuric acid</td><td rowspan=1 colspan=1>Quinine</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>3-Hydroxytyramine</td><td rowspan=1 colspan=1>Ranitidine</td></tr><tr><td rowspan=1 colspan=1>Benzilic acid</td><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>Salicylic acid</td></tr><tr><td rowspan=1 colspan=1>Benzoic acid</td><td rowspan=1 colspan=1>D,L-Isoproterenol</td><td rowspan=1 colspan=1>Serotonin (5- Hydroxytyramine)</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Isoxsuprine</td><td rowspan=1 colspan=1>Sulfamethazine</td></tr><tr><td rowspan=1 colspan=1>Chloralhydrate</td><td rowspan=1 colspan=1>Ketamine</td><td rowspan=1 colspan=1>Sulindac</td></tr><tr><td rowspan=1 colspan=1>Chloramphenicol</td><td rowspan=1 colspan=1>Ketoprofen</td><td rowspan=1 colspan=1>Tetrahydrocortisone, 3-acetate</td></tr><tr><td rowspan=1 colspan=1>Chlorothiazide</td><td rowspan=1 colspan=1>Labetalol</td><td rowspan=1 colspan=1>Tetrahydrocortisone 3-(β-Dglucuronide)</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>Loperamide</td><td rowspan=1 colspan=1>Tetrahydrozoline</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Maprotiline</td><td rowspan=1 colspan=1>Thiamine</td></tr><tr><td rowspan=1 colspan=1>Clonidine</td><td rowspan=1 colspan=1>Meperidine</td><td rowspan=1 colspan=1>Thioridazine</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>Meprobamate</td><td rowspan=1 colspan=1>Triamterene</td></tr><tr><td rowspan=1 colspan=1>(-) Cotinine</td><td rowspan=1 colspan=1>Methoxyphenamine</td><td rowspan=1 colspan=1>DL-Tyrosine</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Nalidixic acid</td><td rowspan=1 colspan=1>Trifluoperazine</td></tr><tr><td rowspan=1 colspan=1>Deoxycorticosterone</td><td rowspan=1 colspan=1>Naloxone</td><td rowspan=1 colspan=1>Trimethoprim</td></tr><tr><td rowspan=1 colspan=1>Dextromethorphan</td><td rowspan=1 colspan=1>Naltrexone</td><td rowspan=1 colspan=1>D L-Tryptophan</td></tr><tr><td rowspan=1 colspan=1>Diclofenac</td><td rowspan=1 colspan=1>Naproxen</td><td rowspan=1 colspan=1>Tyramine</td></tr><tr><td rowspan=1 colspan=1>Diflunisal</td><td rowspan=1 colspan=1>Niacinamide</td><td rowspan=1 colspan=1>Uric acid</td></tr><tr><td rowspan=1 colspan=1>Digoxin</td><td rowspan=1 colspan=1>Nifedipine</td><td rowspan=1 colspan=1>Verapamil</td></tr><tr><td rowspan=1 colspan=1>Diphenhydramine</td><td rowspan=1 colspan=1>Norethindrone</td><td rowspan=1 colspan=1>Zomepirac</td></tr><tr><td rowspan=1 colspan=1>Disopyramide</td><td rowspan=1 colspan=1>Noscapine</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>D,L-Octopamine</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Ecgonine methyl ester</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Y</td></tr></table>

# Effect of Urine Specific Gravity and Urine pH:

To investigate the effect of urine specific gravity and urine $\mathrm { p H }$ , urine samples with 1.000 to 1.035 specific gravity or urine samples with $\mathrm { p H } 4$ to 9 in increments of $1 \mathrm { p H }$ unit were spiked with target drugs at $2 5 \%$ below and $2 5 \%$ above cut-off levels. These samples were tested using three lots of each device. For all devices, results were all positive for samples at $2 5 \%$ above cut-off and all negative for samples at $2 5 \%$ below cut-off.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cut-off concentration appears in the precision/reproducibility section above.

2. Comparison studies:

# a. Method comparison with predicate device:

Method comparison studies for the AssureTech Panel Dip Tests and the AssureTech Quick Cup Tests were performed with three laboratory assistants for each device. Operators ran 80 (40 negative and 40 positive) unaltered clinical samples for each drug. The samples were blind labeled and compared to LC/MS results. The results are presented in the tables below for Oxazepam, Methylenedioxymethamphetamine and Morphine. The data for the remaining drugs of abuse were reported in k153465, k151211, k152025, and k161044.

Oxazepam Panel Dip   

<table><tr><td rowspan=1 colspan=1>PanelDip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecut-off and+50%</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Oxazepam Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Dip CardViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>41261</td><td rowspan=1 colspan=1>289.61</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>35578</td><td rowspan=1 colspan=1>310.69</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>35578</td><td rowspan=1 colspan=1>310.69</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Oxazepam Quick Cup   

<table><tr><td rowspan=1 colspan=1>QuickCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% and cut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecut-off and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Ozaxepam Quick Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Quick CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>41261</td><td rowspan=1 colspan=1>289.61</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>73291</td><td rowspan=1 colspan=1>311.75</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>35578</td><td rowspan=1 colspan=1>310.69</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Methylenedioxymethamphetamine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Panel Dip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% and cut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecut-off and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results for Methylenedioxymethamphetamine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Dip CardViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>61074</td><td rowspan=1 colspan=1>508.34</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>61074</td><td rowspan=1 colspan=1>508.34</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Methylenedioxymethamphetamine Quick Cup

<table><tr><td rowspan=1 colspan=1>QuickCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than-50%</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% and cut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecut-off and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results Methylenedioxymethamphetamine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Quick CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>37623</td><td rowspan=1 colspan=1>491.17</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>61074</td><td rowspan=1 colspan=1>508.34</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>61074</td><td rowspan=1 colspan=1>508.34</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Morphine Panel Dip   

<table><tr><td>Panel Dip</td><td></td><td>Negative</td><td>Low Negative by LC/MS (less than -50%)</td><td>Near Cutoff Negative by LC/MS (Between -50% and cut- off)</td><td>Near Cutoff Positive by LC/MS (Between the cut-off and +50%)</td><td>High Positive by LC/MS (greater than +50%</td></tr><tr><td rowspan="2">Viewer A</td><td>Positive</td><td>0</td><td>0</td><td>1</td><td>14</td><td>25</td></tr><tr><td>Negative</td><td>10</td><td>20</td><td>9</td><td>1</td><td>0</td></tr><tr><td colspan="1" rowspan="2">ViewerB</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">ViewerC</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr></table>

Discordant Results for Morphine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Dip CardViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>90003</td><td rowspan=1 colspan=1>278.16</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>80161</td><td rowspan=1 colspan=1>280.75</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>59386</td><td rowspan=1 colspan=1>322.85</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>98199</td><td rowspan=1 colspan=1>306.08</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>98199</td><td rowspan=1 colspan=1>306.08</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Morphine Quick Cup   

<table><tr><td rowspan=1 colspan=1>QuickCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% and cut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecut-off and+50%</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results for Morphine Quick Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>Quick CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>80161</td><td rowspan=1 colspan=1>280.75</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>80161</td><td rowspan=1 colspan=1>280.75</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>59386</td><td rowspan=1 colspan=1>322.85</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Lay-user Study

A lay user study was performed at three intended user sites with 280 lay persons for each device format (Panel Dip and Quick Cup) and morphine cut-off of $3 0 0 ~ \mathrm { { n g / m L } }$ and 2000 $\mathrm { { n g / m L } }$ . The lay users who tested the Panel Dip format were different from those who tested the Quick Cup format. The lay users had diverse educational and professional

backgrounds and ranged in age from 18 to $> 5 0$ years. Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drugs into drug free-pooled urine specimens. The concentrations of the samples were confirmed by LC/MS. Each sample was aliquoted into individual containers and blindlabeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. Each device (panel dip and panel cup) containing all drugs was tested. Results were similar between panel dip and panel cup formats. Below, results are provided for the Panel Dip format.

Comparison between LC/MS and Lay Person Results for Amphetamine:   

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>248</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>508</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>752</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1255</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1506</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1748</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

Comparison between LC/MS and Lay Person Results for Barbiturates:   

<table><tr><td colspan="1" rowspan="2">% of Cut-off</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="1" rowspan="2">DrugConcentration byLC/MS (ng/mL)</td><td colspan="2" rowspan="1">Lay person Results</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100% Cut-off</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">-75% Cut-off</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">73</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">-50% Cut-off</td><td colspan="1" rowspan="1">140</td><td colspan="1" rowspan="1">151</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">140</td></tr><tr><td colspan="1" rowspan="1">-25% Cut-off</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">223</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">+25% Cut-off</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">378</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+50% Cut-off</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">456</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+75% Cut-off</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">521</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Cocaine:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>76</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>222</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>377</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>452</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>528</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Buprenorphine:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>7.2</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>15.4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>17.3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Methamphetamine:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>255</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>496</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>757</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1258</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1504</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1744</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Methadone:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>155</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>228</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>377</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>454</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>528</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Morphine:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>155</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>371</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>447</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>521</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Oxycodone:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>53</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>72</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>171</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Phencyclidine :

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Tetrahydrocannabinol:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>64</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Benzodiazepines:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>146</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>228</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>377</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>452</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>519</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

# Comparison between LC/MS and Lay Person Results for Methylenedioxymethamphetamine:

<table><tr><td rowspan=2 colspan=1>% of Cut-off</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>DrugConcentration byLC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>121</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>-50% Cut-off</td><td rowspan=1 colspan=1>140</td><td rowspan=1 colspan=1>253</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>140</td></tr><tr><td rowspan=1 colspan=1>-25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>371</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>+25% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>628</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>+50% Cut-off</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>756</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>+75% Cut-off</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>879</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td></tr></table>

Lay-users were also given surveys on the ease of understanding the package insert instructions. All lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on each package insert and the

scores revealed a reading Grade Level of 7.

b. Matrix comparison: Not applicable.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.